Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
US5691336A · kind A · utility
79Cited by
13References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 1995 |
| Grant date | Nov 25, 1997 |
| Priority date | — |
| Expiry date | Sep 8, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65583
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma, and emesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.